Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 14, Number 12—December 2008

CME ACTIVITY - Research

Clinical Characteristics and Molecular Subtyping of Vibrio vulnificus Illnesses, Israel

Ronit Zaidenstein, Chantal Sadik, Larisa Lerner, Lea Valinsky, June Kopelowitz, Ruth Yishai, Vered Agmon, Michele B. Parsons, Cheryl Bopp, and Miriam WeinbergerComments to Author 
Author affiliations: Assaf Harofeh Medical Center, Zerifin, Israel (R. Zaidenstein, M. Weinberger); Israel Ministry of Health, Jerusalem, Israel (C. Sadik, L. Lerner, L. Valinsky, J. Kopelowitz, R. Yishai, V. Agmon); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M. Parsons, C. Bopp); Tel Aviv University, Ramat Aviv, Israel (M. Weinberger)

Main Article

Figure 3

Figure 3 - Age distribution of patients with laboratory-confirmed and suspected Vibrio vulnificus biotype 3 infections.

Figure 3. Age distribution of patients with laboratory-confirmed and suspected Vibrio vulnificus biotype 3 infections.

Main Article

TOP